The EIB requires maintenance services for flow cytometry equipment in order to effect emergency repairs and to maintain the equipment in optimal operating condition.
Ended Awarded Last action
- Contract number
- 75N91021F00001
- Awardee
-
Becton, Dickinson And Company UEI MM5ZHL8SRFY5 Part of Becton, Dickinson And Co
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $17,928
Award facts
- Contract value 100% obligated
- $17,928.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 811219 Other Electronic and Precision Equipment Repair and Maintenance
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a $17,928 firm fixed price Blanket Purchase Agreement (BPA) call to Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, for maintenance services on flow cytometry equipment. The contract, awarded on May 21, 2021, with an ultimate completion date of May 20, 2022, supports the Environmental Imaging and Biomedical Instrumentation (EIB) facility in Bethesda, Maryland. The maintenance services are intended to enable emergency repairs and preserve optimal operating condition of the agency's flow cytometry instrumentation, critical tools for cancer research and cell analysis applications.
This award represents a call against BD's existing BPA vehicle and reflects the contractor's established position as a primary supplier of flow cytometry systems, reagents, and technical support to federal research institutions. BD Biosciences holds multiple significant indefinite delivery contracts with the Department of Veterans Affairs and NIH components for flow cytometry equipment and supplies, demonstrating its specialized capabilities and competitive standing in this sector. The contract includes no small business set-aside designation, consistent with BD's status as a large, established medical technology manufacturer. The award supports the National Cancer Institute's research infrastructure by ensuring reliable access to sophisticated flow cytometry equipment essential for advancing cancer research initiatives.
Quick answers
Who was awarded contract 75N91021F00001?
75N91021F00001 was awarded to Becton, Dickinson And Company by National Cancer Institute (National Institutes of Health) on May 21, 2021.
How much is contract 75N91021F00001 worth?
The government has obligated $17,928 on 75N91021F00001.
Is contract 75N91021F00001 an order under another contract?
Yes. 75N91021F00001 is a BPA call under HHSN263201600133B, a blanket purchase agreement.
Was contract 75N91021F00001 competed?
The extent of competition for 75N91021F00001 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award